Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
株式のランク
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
株価
$8.03
時価総額
$6.31B
変化（1日）
1.07%
変化（1年）
-8.04%
国
CN
取引 Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
カテゴリー
Healthcare
Shenzhen New Industries Biomedical Engineering Co., Ltd.（300832）のP/S比率
October 2026 時点のP/S比率 TTM: 8.75
Shenzhen New Industries Biomedical Engineering Co., Ltd. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 8.75 です。2024 年末時点でのP/S比率は 12.27 でした。
Shenzhen New Industries Biomedical Engineering Co., Ltd. の P/S 比率の履歴（2012 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 8.75 | -9.40% |
| 2025 | 9.66 | -21.32% |
| 2024 | 12.27 | -21.47% |
| 2023 | 15.63 | 20.88% |
| 2022 | 12.93 | -4.70% |
| 2021 | 13.57 | -45.22% |
| 2020 | 24.77 | 123.84% |
| 2019 | 11.06 | -8.57% |
| 2018 | 12.10 | -17.57% |
| 2017 | 14.68 | -19.11% |
| 2016 | 18.15 | -19.42% |
| 2015 | 22.52 | -24.61% |
| 2014 | 29.87 | -30.65% |
| 2013 | 43.08 | -31.74% |
| 2012 | 63.12 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 3.74 | -57.32% |
US
|
|
| 3.23 | -63.08% |
IE
|
|
| 4.58 | -47.71% |
US
|
|
| 3.07 | -64.89% |
US
|
|
| 2.02 | -76.95% |
DE
|
